# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k182530   
B. Purpose for Submission New device   
C. Measurand Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine. Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline, d-Propoxyphene.   
D. Type of Test Qualitative immunochromatographic assay   
E. Applicant Shenzhen Bioeasy Biotechnology Co., Ltd   
F. Proprietary and Established Names BIOEASY Multi-Drug Test Cup   
G. Regulatory Information

<table><tr><td colspan="1" rowspan="1">Product Code</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">Regulation Section</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">NFTAmphetamine</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">21 CFR § 862.3100,Amphetamine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NFWCannabinoids</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3870,Cannabinoids Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NFYCocaine</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3250,Cocaine and Cocaine MetabolitesTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGGMethamphetamine</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3610,Methamphetamine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGIMorphine</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3640,Morphine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NFVOxazepam</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3170,Benzodiazepine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGLOxycodone</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3650,Opiate Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">PTHSecobarbital</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3150,Barbiturate Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGLBuprenorphine</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3650,Opiate Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGGMethylenedioxy-methamphetamine</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3610,Methamphetamine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGMPhencyclidine</td><td colspan="1" rowspan="1">unclassified</td><td colspan="1" rowspan="1">Enzyme ImmunoassayPhencyclidine</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">PTGMethadone</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3620,Methadone Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">QAWNortriptyline</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR, 862.3910,Tricyclic Antidepressant Drugs TestSystem</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">QBFPropoxyphene</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR, 862.3700,Propoxyphene Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr></table>

# H. Intended Use

Intended Use1. See Indications for Use below.

2. Indications for Use

BIOEASY Multi-Drug Test Cup Tests are competitive binding, lateral flow immunochromatographic assays for qualitative ad simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and d-Propoxyphene in human urine at the cutoff concentrations of:

<table><tr><td colspan="1" rowspan="1">Drug Identifier</td><td colspan="1" rowspan="1">Cut-off Level</td></tr><tr><td colspan="1" rowspan="1">Amphetamine</td><td colspan="1" rowspan="1">1000ng/mL</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">300 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">300 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Marijuana</td><td colspan="1" rowspan="1">50 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">1000 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">300 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">300 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">10 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxy-methamphetamine</td><td colspan="1" rowspan="1">500 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">25 ng/ml</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">300 ng/ml</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1000 ng/mL</td></tr><tr><td colspan="1" rowspan="1">d-Propoxyphene</td><td colspan="1" rowspan="1">300 ng/mL</td></tr></table>

Configuration of the BIOEASY Multi-Drug Test Cup tests can consist of any combination of the above listed drug analytes.

The test may yield positive results for the prescription drugs Buprenorphine, Nortriptyline, Oxazepam, Secobarbital, Propoxyphene, and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. The test provides only preliminary test results. A more specific alternative chemical method must be used to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method.

For in vitro diagnostic use only.

# I. Device Description:

The BIOEASY Multi-Drug Test Cup tests are immunochromatographic assays that use a lateral flow system for the qualitative detection of Amphetamines, Oxazepam, Cocaine, Marijuana, Methamphetamines, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline, and dPropoxyphene (target analytes) in human urine. The products are single-use in vitro diagnostic devices. Each test kit contains a Test Device, a package insert, and a urine cup for sample collection. Each test device is sealed with a desiccant in an aluminum pouch.

# J. Substantial Equivalence Information:

1. Predicate device name: Rapid Single/Multi-drug Test Cup

2. Predicate 510(k) number k153050

3. Comparison with predicate:

Similarities:

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate -k153050</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitative determination ofdrugs of abuse in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrator and Cut-OffValues</td><td rowspan=1 colspan=1>Amphetamine (AMP): 1,000 ng/mlOxazepam (BZO):300 ng/mlCocaine(COC): 300 ng/mlMarijuana (THC):50 ng/mlMethamphetamine (MET): 1,000 ng/mlMorphine (MOR): 300ng/mlOxycodone(OXY) : 100 ng/mlSecobarbital (BAR): 300 ng/mlBuprenorphine (BUP): 10 ng/mlMethylenedioxy-methamphetamine(MDMA): 500 ng/mlPhencyclidine (PCP): 25 ng/mlMethadone (MTD): 300 ng/mlNortriptyline (TCA): 1000 ng/mlPropoxyphene (PPX): 300 ng/ml</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays based on theprinciple of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For over-the-counter</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Cup</td><td rowspan=1 colspan=1>Same</td></tr></table>

Differences:

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate -k153050</td></tr><tr><td rowspan=1 colspan=1>Number of drugsdetected</td><td rowspan=1 colspan=1>14 drugs of abuse</td><td rowspan=1 colspan=1>16 drugs ofabuse</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable)

None identified.

# L. Test Principle:

The BIOEASY Multi-Drug Test Cup is a lateral flow chromatographic immunoassay. During testing, a urine specimen migrates upward by capillary action. If target drugs present in the urine specimen are below the cut-off concentration, it will not saturate the binding sites of its specific monoclonal mouse antibody coated on the particles. The antibody-coated particles will then be captured by immobilized drug-conjugate and a visible colored line will show up in the test region. The colored line will not form in the test line region if the target drug level exceeds its cut-off concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices regardless of the presence of drug or metabolite in the sample to indicate the tests have been performed properly.

# M. Performance Characteristics (if/when applicable):

1. Analytical Performance

# a. Precision Reproducibility

Precision studies were conducted for samples with concentrations of $- 1 0 0 \%$ cut off, $- 7 5 \%$ cut off, $- 5 0 \%$ cut off, $- 2 5 \%$ cut off, $+ 2 5 \%$ cut off, $+ 5 0 \%$ cut off, $+ 7 5 \%$ cut off and $+ 1 0 0 \%$ cut off. The samples were prepared by spiking drug into negative urine samples. Each drug concentration was confirmed by GC/MS. All sample aliquots were blindly labeled by the person who prepared the samples and did not take part in the sample testing. For each concentration, tests were performed two runs per day for 25 days per device in a randomized order. The results are summarized in the following tables:

Amphetamine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Secobarbital   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+ 75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Buprenorphine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+ 75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Oxazepam   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Cocaine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Methylenedioxy-methamphetamine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Methamphetamine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Morphine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+ 75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Methadone   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Oxycodone   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Phencyclidine   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+ 75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+ 75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Nortriptyline   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+ 75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Marijuana   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cut off</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

$b$ . Linearity/assay reportable range:

Not applicable, these devices are intended for qualitative use only.

c. Traceability, Stability, Expected Values (controls, calibrators, or methods)

The stability study protocols and acceptance criteria were reviewed and found to be acceptable.

d. Detection limit: Not applicable.

e. Analytical specificity:

Cross-reactivity:

Analytical specificity studies were performed to determine whether drugs and drug metabolites within the same class of drugs or with similar molecular structures cross-react in the test systems. Reference standards for the various metabolites and compounds were prepared at $1 0 0 ~ \mu \mathrm { g / m L }$ in pooled negative human urine samples. Compounds that tested positive were serially diluted until a negative result was observed. Results shown are expressed as the minimum concentration producing a positive result in the indicated assay.

<table><tr><td colspan="1" rowspan="1">AMP(Amphetamine)(D  Amphetamine Cut-off=1000ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">D - Amphetamine</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">L - Amphetamine</td><td colspan="1" rowspan="1">Positive at 20000 ng/mL</td><td colspan="1" rowspan="1">5%</td></tr><tr><td colspan="1" rowspan="1">DL - Amphetamine</td><td colspan="1" rowspan="1">Positive at 3000 ng/mL</td><td colspan="1" rowspan="1">33%</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">Positive at 30000 ng/mL</td><td colspan="1" rowspan="1">3.3%</td></tr><tr><td colspan="1" rowspan="1">Hydroxyamphetamine</td><td colspan="1" rowspan="1">Positive at 8000 ng/mL</td><td colspan="1" rowspan="1">12.5%</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">Positive at 20000 ng/mL</td><td colspan="1" rowspan="1">5%</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">Positive&gt;100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">Positive&gt;100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">Positive &gt;100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxyethylamphetamine (MDE)</td><td colspan="1" rowspan="1">Positive&gt;100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">3,4-methylenedioxy-methamphetamine(MDMA)</td><td colspan="1" rowspan="1">Positive&gt; 100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>BAR(Barbital)(Secobarbital, Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>Positive at 1000 ng/mL</td><td rowspan=1 colspan=1>30%</td></tr><tr><td rowspan=1 colspan=1>Alphenal</td><td rowspan=1 colspan=1>Positive at 62.5 ng/mL</td><td rowspan=1 colspan=1>480%</td></tr><tr><td rowspan=1 colspan=1>Aprobarbital</td><td rowspan=1 colspan=1>Positive at 250 ng/mL</td><td rowspan=1 colspan=1>120%</td></tr><tr><td rowspan=1 colspan=1>Butabarbital</td><td rowspan=1 colspan=1>Positive at 100 ng/mL</td><td rowspan=1 colspan=1>300%</td></tr><tr><td rowspan=1 colspan=1>Butethal</td><td rowspan=1 colspan=1>Positive at 500 ng/mL</td><td rowspan=1 colspan=1>60%</td></tr><tr><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>Positive at 5000 ng/mL</td><td rowspan=1 colspan=1>6%</td></tr><tr><td rowspan=1 colspan=1>Cyclopentobarbital</td><td rowspan=1 colspan=1>Positive at 500 ng/mL</td><td rowspan=1 colspan=1>60%</td></tr><tr><td rowspan=1 colspan=1>Pentobarbital</td><td rowspan=1 colspan=1>Positive at 200 ng/mL</td><td rowspan=1 colspan=1>150%</td></tr><tr><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>BUP(Buprenorphine)(Buprenorphine, Cut-off=10 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Positive at 10 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine -3-D-Glucuronide</td><td rowspan=1 colspan=1>Positive at 10 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine-3-D-Glucuronide</td><td rowspan=1 colspan=1>Positive at 10 ng/mL</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Positive&gt; 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.01%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>Positive&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.01%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>Positive&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.01%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">BZO(Benzodiazepines)(Oxazepam, Cut-off=300 ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">Positive at 300 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">Positive at 150 ng/mL</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">a-Hydroxyalprazolam</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Positive at 63 ng/mL</td><td colspan="1" rowspan="1">476.2%</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">Positive at 2500 ng/mL</td><td colspan="1" rowspan="1">12%</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">Positive at 75 ng/mL</td><td colspan="1" rowspan="1">400%</td></tr><tr><td colspan="1" rowspan="1">Clorazepate dipotassium</td><td colspan="1" rowspan="1">Positive at 100 ng/mL</td><td colspan="1" rowspan="1">300%</td></tr><tr><td colspan="1" rowspan="1">Desalkylflurazepam</td><td colspan="1" rowspan="1">Positive at 500 ng/mL</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Positive at 500 ng/mL</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Estazolam</td><td colspan="1" rowspan="1">Positive at 500 ng/mL</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">Positive &gt; 50000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.6%</td></tr><tr><td colspan="1" rowspan="1">D,L-Lorazepam</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">3%</td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">3%</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">Positive at 75 ng/mL</td><td colspan="1" rowspan="1">400%</td></tr><tr><td colspan="1" rowspan="1">Norchlordiazepoxide</td><td colspan="1" rowspan="1">Positive at 62.5 ng/mL</td><td colspan="1" rowspan="1">480%</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">Positive at 125 ng/mL</td><td colspan="1" rowspan="1">240%</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">Positive at 75 ng/mL</td><td colspan="1" rowspan="1">400%</td></tr><tr><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">33%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>COC(Cocaine)(Benzoylecgonine, Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Cocaine HC1</td><td rowspan=1 colspan=1>Positive at 750 ng/mL</td><td rowspan=1 colspan=1>40%</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>Positive at 12500 ng/mL</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=1 colspan=1>Ecgonine</td><td rowspan=1 colspan=1>Positive at 32000 ng/mL</td><td rowspan=1 colspan=1>0.9%</td></tr><tr><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>Positive at 100000 ng/mL</td><td rowspan=1 colspan=1>0.3%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">MDMA(Methylenedioxymethamphetamine)(Methylenedioxymethamphetamine,Cut-off=500 ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">Positive at 500 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">Positive at 5000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">Positive at 300 ng/mL</td><td colspan="1" rowspan="1">166.7%</td></tr><tr><td colspan="1" rowspan="1">d-methamphetamine</td><td colspan="1" rowspan="1">Positive&gt;50000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">d-amphetamine</td><td colspan="1" rowspan="1">Positive&gt;50000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">1-amphetamine</td><td colspan="1" rowspan="1">Positive&gt;50000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">1-methamphetamine</td><td colspan="1" rowspan="1">Positive&gt;50000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">MET(Methamphetamine)(D(+)-Methamphetamine, Cut-off=1000ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">D(+)-Methamphetamine</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxy-n-ethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">D/L-Methamphetamine</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">Positive&gt;100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">Positive &gt;100000ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Positive at 50000 ng/mL</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">(+/-)-Ephedrine</td><td colspan="1" rowspan="1">Positive at 4000 ng/mL</td><td colspan="1" rowspan="1">25%</td></tr><tr><td colspan="1" rowspan="1">L-Methamphetamine</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">Positive&gt;100000 ng/mL</td><td colspan="1" rowspan="1">&lt;1%</td></tr><tr><td colspan="1" rowspan="1">β-Phenylethylamine</td><td colspan="1" rowspan="1">Positive at 7500 ng/mL</td><td colspan="1" rowspan="1">13.3%</td></tr><tr><td colspan="1" rowspan="1">Trimethobenzamide</td><td colspan="1" rowspan="1">Positive at 20000 ng/mL</td><td colspan="1" rowspan="1">5%</td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-methylenedioxymethamphetamine(MDMA)</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>MOP(Morphine)(Morphine, Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>Positive at 310 ng/mL</td><td rowspan=1 colspan=1>96.8%</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>Positive at 25000 ng/mL</td><td rowspan=1 colspan=1>1.2%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>Positive at 10000 ng/mL</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>Positive &gt; 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>6-Acetylmorphine</td><td rowspan=1 colspan=1>Positive at 250 ng/mL</td><td rowspan=1 colspan=1>120%</td></tr><tr><td rowspan=1 colspan=1>Morphine-3-β-D-glucuronide</td><td rowspan=1 colspan=1>Positive at 10000 ng/mL</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>Normorphine</td><td rowspan=1 colspan=1>Positive at 100000 ng/mL</td><td rowspan=1 colspan=1>0.3%</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Positive &gt; 10000 ng/mL</td><td rowspan=1 colspan=1>&lt;3%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>Positive &gt;10000 ng/mL</td><td rowspan=1 colspan=1>&lt;3%</td></tr><tr><td rowspan=1 colspan=1>Procaine</td><td rowspan=1 colspan=1>Positive &gt;10000 ng/mL</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>Positive &gt;10000 ng/mL</td><td rowspan=1 colspan=1>&lt;3%</td></tr><tr><td rowspan=1 colspan=1>Heroin</td><td rowspan=1 colspan=1>Positive at 500 ng/mL</td><td rowspan=1 colspan=1>60%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">MTD(Methadone)(Methadone, Cut-off=300 ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Positive at 300 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Positive at 5000 ng/mL</td><td colspan="1" rowspan="1">6%</td></tr><tr><td colspan="1" rowspan="1">LAAM</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">3%</td></tr><tr><td colspan="1" rowspan="1">Alpha Methadol</td><td colspan="1" rowspan="1">Positive at 2000 ng/mL</td><td colspan="1" rowspan="1">15%</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">Positive&gt; 100000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.3%</td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">Positive &gt; 100000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>OXY(Oxycodone)(Oxycodone, Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Positive at 100 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Dihydrocodeine</td><td rowspan=1 colspan=1>Positive &gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.1%</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>Positive&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.1%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>Positive&gt;&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.1%</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Positive&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.1%</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Positive&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.1%</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>Positive&gt; 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.1%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>Positive at 250 ng/mL</td><td rowspan=1 colspan=1>40%</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>Positive at 3125 ng/mL</td><td rowspan=1 colspan=1>3.2%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>PCP(Phencyclidine)(Phencyclidine, Cut-off=25 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>Positive at 25 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>4-Hydroxyphencyclidine</td><td rowspan=1 colspan=1>Positive at 75 ng/mL</td><td rowspan=1 colspan=1>33.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>PPX(Propoxyphene)(d-Propoxyphene, Cut-off=300ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>d-Propoxyphene</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>D-Norpropoxyphene</td><td rowspan=1 colspan=1>Positive at 333 ng/mL</td><td rowspan=1 colspan=1>90.1%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">TCA(Nortriptyline)(Nortriptyline, Cut-off=1000 ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">%Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Positive at 750 ng/mL</td><td colspan="1" rowspan="1">133.3%</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">Positive at 200 ng/mL</td><td colspan="1" rowspan="1">500%</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">Positive at 1250 ng/mL</td><td colspan="1" rowspan="1">80%</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Positive at 625 ng/mL</td><td colspan="1" rowspan="1">160%</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Positive at 2000 ng/mL</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">Positive at 1500 ng/mL</td><td colspan="1" rowspan="1">66.7%</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">Positive at 25000 ng/mL</td><td colspan="1" rowspan="1">4%</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">Positive at 3000 ng/mL</td><td colspan="1" rowspan="1">33.3%</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">Positive at 5000 ng/mL</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Norclomipramine</td><td colspan="1" rowspan="1">Positive at 3000 ng/mL</td><td colspan="1" rowspan="1">33.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>THC(Cannabinoids)(11-nor-∆9-THC-9-COOH, Cut-off = 50ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-Hydroxy-∆9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-Nor-Δ8-Tetrahydrocannabinol-9-COOH</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>Positive at 20000 ng/mL</td><td rowspan=1 colspan=1>0.25%</td></tr><tr><td rowspan=1 colspan=1>Δ8-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>Positive at 15000 ng/mL</td><td rowspan=1 colspan=1>0.33%</td></tr><tr><td rowspan=1 colspan=1>9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>Positive at 15000 ng/mL</td><td rowspan=1 colspan=1>0.33%</td></tr><tr><td rowspan=1 colspan=1>Cannabidiol</td><td rowspan=1 colspan=1>Positive&gt;100000 ng/mL</td><td rowspan=1 colspan=1>&lt;0.05%</td></tr><tr><td rowspan=1 colspan=1>11-Nor-Δ9-THC-carboxy glucuronide</td><td rowspan=1 colspan=1>Positive at 75 ng/mL</td><td rowspan=1 colspan=1>66.7%</td></tr><tr><td rowspan=1 colspan=1>(-)-11-nor-9-carboxy-Δ 9-THC</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-Hydroxy-∆9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-Nor-Δ8-Tetrahydrocannabinol-9-COOH</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>Positive at 20000 ng/mL</td><td rowspan=1 colspan=1>0.25%</td></tr></table>

# Interference

Potential interfering substances found in human urine of physiological or pathological conditions were added at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ (albumin was tested at $1 0 0 \mathrm { m g / d L }$ ) to drug-free urine and urine with target drug concentrations at $2 5 \%$ below and $2 5 \%$ above Cut-off levels. These urine samples were tested using three batches of each device. No interference was observed for any compounds tested, and the list of compounds tested is provided in the following table:

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">Oxalic acid</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Oxolinic acid</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Ethanol</td><td colspan="1" rowspan="1">Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Albumin (100 mg/dL)</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Penicillin G</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">(±)-Propranolol</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Isoproterenol</td><td colspan="1" rowspan="1">Serotonin (5-Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chloral hydrate</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-(β-Dglucuronide)</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-acetate</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">(-)-Cotinine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">DL-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">(±)-Octopamine</td><td colspan="1" rowspan="1"></td></tr></table>

# f. Effect of Urine Specific Gravity and Urine pH

To investigate potential interferences due to urine specific gravity and urine $\mathrm { p H }$ , urine samples, with 1.000 to 1.035 specific gravity, or urine samples with $\mathrm { p H } 4$ to 9, were spiked with target drugs at $2 5 \%$ below and $2 5 \%$ above Cut-Off levels. These samples were tested using three lots of each device. For all devices and all lots tested, results were all positive for samples at $+ 2 5 \%$ Cut-Off and all negative for samples below $2 5 \%$ Cut-Off.

# g. Assay Cut-off

See M.1.a., above.

2. Comparison Studies

Method comparison studies for the BOEASY Multi-Drug Test Cup tests were performed in-house with three laboratory assistants for each device. Operators ran 80(40 negative and 40 positive) unaltered clinical samples for each target drug. The samples were blind-labeled and compared to results obtained by LC/MS. The results are presented in the tables below:

Discordant Results   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>AMPC439</td><td rowspan=1 colspan=1>981</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>AMPC449</td><td rowspan=1 colspan=1>768</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>AMPC439</td><td rowspan=1 colspan=1>981</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>AMPC449</td><td rowspan=1 colspan=1>768</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>AMPC412</td><td rowspan=1 colspan=1>976</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>AMPC387</td><td rowspan=1 colspan=1>981</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>AMPC412</td><td rowspan=1 colspan=1>976</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>AMPC493</td><td rowspan=1 colspan=1>961</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>AMPC387</td><td rowspan=1 colspan=1>981</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>AMPC341</td><td rowspan=1 colspan=1>1010</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>AMPC482</td><td rowspan=1 colspan=1>1010</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>AMPC482</td><td rowspan=1 colspan=1>1010</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>AMPC341</td><td rowspan=1 colspan=1>1010</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>AMPC352</td><td rowspan=1 colspan=1>1120</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Secobarbital   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby LC/MS(lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>HighPositive byLC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BARC477</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BARC375</td><td rowspan=1 colspan=1>265</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BARC477</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BARC375</td><td rowspan=1 colspan=1>265</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>BARC364</td><td rowspan=1 colspan=1>269</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BARC384</td><td rowspan=1 colspan=1>312</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BARC384</td><td rowspan=1 colspan=1>312</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Buprenorphine   

<table><tr><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>LowNegativeby LC/MS(less than-50%)</td><td rowspan=2 colspan=1>Near CutoffNegativeby LC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive by</td><td rowspan=2 colspan=1>HighPositive byLC/MS(greater than+50%)</td></tr><tr><td rowspan=1 colspan=1>LC/MS(Between thecutoff and+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BUPC379</td><td rowspan=1 colspan=1>9.67</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>BUPC359</td><td rowspan=1 colspan=1>8.94</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>BUPC379</td><td rowspan=1 colspan=1>9.67</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BUPC322</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BUPC429</td><td rowspan=1 colspan=1>11.2</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BUPC322</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BUPC348</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>BUPC348</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Oxazepam

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS (lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoffand+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td colspan="1" rowspan="1">Viewer</td><td colspan="1" rowspan="1">Sample Number</td><td colspan="1" rowspan="1">LC/MS Result</td><td colspan="1" rowspan="1">BIOEASY CupViewer Results</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">BZOC343</td><td colspan="1" rowspan="1">298</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">BZOC322</td><td colspan="1" rowspan="1">296</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">BZOC322</td><td colspan="1" rowspan="1">296</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">BZOC343</td><td colspan="1" rowspan="1">298</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">BZOC435</td><td colspan="1" rowspan="1">292</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">BZOC301</td><td colspan="1" rowspan="1">314</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer A</td><td colspan="1" rowspan="1">BZOC348</td><td colspan="1" rowspan="1">312</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer B</td><td colspan="1" rowspan="1">BZOC348</td><td colspan="1" rowspan="1">312</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Viewer C</td><td colspan="1" rowspan="1">BZOC301</td><td colspan="1" rowspan="1">314</td><td colspan="1" rowspan="1">Negative</td></tr></table>

Cocaine   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS (lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoffand+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COCC368</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COCC340</td><td rowspan=1 colspan=1>294</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCC368</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCC315</td><td rowspan=1 colspan=1>282</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COCC340</td><td rowspan=1 colspan=1>294</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COCC317</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COCC317</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Methylnedioxymethamphetamine

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS(lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoffand+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MDMAC310</td><td rowspan=1 colspan=1>490</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MDMAC306</td><td rowspan=1 colspan=1>497.5</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MDMAC365</td><td rowspan=1 colspan=1>484.5</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MDMAC310</td><td rowspan=1 colspan=1>490</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MDMAC306</td><td rowspan=1 colspan=1>497.5</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MDMAC316</td><td rowspan=1 colspan=1>505</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MDMAC316</td><td rowspan=1 colspan=1>505</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MDMAC484</td><td rowspan=1 colspan=1>565</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Methamphetamine

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS (lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoffand+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greaterthan+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METC498</td><td rowspan=1 colspan=1>921</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METC479</td><td rowspan=1 colspan=1>984</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METC467</td><td rowspan=1 colspan=1>973</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>METC479</td><td rowspan=1 colspan=1>984</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METC343</td><td rowspan=1 colspan=1>1020</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>METC473</td><td rowspan=1 colspan=1>1110</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>METC473</td><td rowspan=1 colspan=1>1110</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Morphine   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Low Negativeby LC/MS (lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between -50%and cutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoffand+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MOPC355</td><td rowspan=1 colspan=1>287</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MOPC429</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MOPC408</td><td rowspan=1 colspan=1>286</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MOPC429</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MOPC408</td><td rowspan=1 colspan=1>286</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MOPC433</td><td rowspan=1 colspan=1>276</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MOPC393</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MOPC416</td><td rowspan=1 colspan=1>339</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MOPC416</td><td rowspan=1 colspan=1>339</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MOPC393</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Methadone

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MTDC314</td><td rowspan=1 colspan=1>289</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MTDC389</td><td rowspan=1 colspan=1>299</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTDC314</td><td rowspan=1 colspan=1>289</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTDC408</td><td rowspan=1 colspan=1>290</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MTDC389</td><td rowspan=1 colspan=1>299</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MTDC373</td><td rowspan=1 colspan=1>279</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>MTDC408</td><td rowspan=1 colspan=1>290</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MTDC447</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTDC447</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MTDC427</td><td rowspan=1 colspan=1>336</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Oxycodone   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OXYC467</td><td rowspan=1 colspan=1>97.5</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OXYC369</td><td rowspan=1 colspan=1>94.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OXYC334</td><td rowspan=1 colspan=1>98.4</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OXYC470</td><td rowspan=1 colspan=1>95.1</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OXYC467</td><td rowspan=1 colspan=1>97.5</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OXYC310</td><td rowspan=1 colspan=1>96.1</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OXYC470</td><td rowspan=1 colspan=1>95.1</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OXYC310</td><td rowspan=1 colspan=1>96.1</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OXYC369</td><td rowspan=1 colspan=1>94.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OXYC334</td><td rowspan=1 colspan=1>98.4</td><td rowspan=1 colspan=1>Positive</td></tr></table>

Phencyclidine   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PCPC441</td><td rowspan=1 colspan=1>24.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PCPC411</td><td rowspan=1 colspan=1>24.7</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PCPC441</td><td rowspan=1 colspan=1>24.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PCPC462</td><td rowspan=1 colspan=1>24.7</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PCPC411</td><td rowspan=1 colspan=1>24.7</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PCPC477</td><td rowspan=1 colspan=1>25.3</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PCPC368</td><td rowspan=1 colspan=1>27.8</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PCPC477</td><td rowspan=1 colspan=1>25.3</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPXC472</td><td rowspan=1 colspan=1>286</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPXC472</td><td rowspan=1 colspan=1>286</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPXC320</td><td rowspan=1 colspan=1>278</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPXC320</td><td rowspan=1 colspan=1>278</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPXC493</td><td rowspan=1 colspan=1>318</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPXC382</td><td rowspan=1 colspan=1>306</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPXC382</td><td rowspan=1 colspan=1>306</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPXC493</td><td rowspan=1 colspan=1>318</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Nortriptyline   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCAC319</td><td rowspan=1 colspan=1>979</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCAC470</td><td rowspan=1 colspan=1>944</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCAC319</td><td rowspan=1 colspan=1>979</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCAC346</td><td rowspan=1 colspan=1>958</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCAC346</td><td rowspan=1 colspan=1>958</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCAC470</td><td rowspan=1 colspan=1>944</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCAC479</td><td rowspan=1 colspan=1>1190</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCAC398</td><td rowspan=1 colspan=1>1050</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCAC331</td><td rowspan=1 colspan=1>1180</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCAC479</td><td rowspan=1 colspan=1>1190</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCAC398</td><td rowspan=1 colspan=1>1050</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCAC331</td><td rowspan=1 colspan=1>1180</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Marijuana

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>THCC402</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>THCC368</td><td rowspan=1 colspan=1>48.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>THCC363</td><td rowspan=1 colspan=1>46.95</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>THCC402</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>THCC363</td><td rowspan=1 colspan=1>46.95</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>THCC368</td><td rowspan=1 colspan=1>48.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>THCC478</td><td rowspan=1 colspan=1>55.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>THCC493</td><td rowspan=1 colspan=1>50.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>THCC496</td><td rowspan=1 colspan=1>57.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>THCC478</td><td rowspan=1 colspan=1>55.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>THCC318</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>THCC493</td><td rowspan=1 colspan=1>50.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>THCC318</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>THCC496</td><td rowspan=1 colspan=1>57.5</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Lay user study

A lay user study was performed at three intended user sites with 300 lay persons. The lay users had diverse ages and educational and professional backgrounds. Urine samples were prepared at multiple concentrations (Negative, $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff) by spiking drugs into drug free pooled specimens. The concentrations of the samples were confirmed by LC/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, one blind labeled sample and a device, and no additional training. Summary results are shown below.

The results summary for AMP:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentration byLC/MS/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>261</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>507</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>771</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1290</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1560</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1870</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for BAR:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75.9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>360</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>429</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>501</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for COC:

<table><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="1" rowspan="2">Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay Person Results</td><td colspan="1" rowspan="2">The percentage ofcorrect results (%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">81.5</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">151</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">395</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">455</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">520</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

The results summary for BUP:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>2.57</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>5.14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>6.76</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>12.8</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>15.1</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>17.2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for MET:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>268</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>526</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>769</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1270</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1560</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1780</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for MTD:

<table><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="1" rowspan="2">Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay Person Results</td><td colspan="1" rowspan="2">The percentage ofcorrect results (%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">76.8</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">147</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">226</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">441</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">504</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

The results summary for MOP:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>79</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>158</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>246</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>389</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>469</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>530</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for OXY:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>24.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>49.3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>71.1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>147</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>169</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for PCP:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>6.27</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>17.9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>30.8</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>36.4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>42.8</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for THC:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>25.3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>79</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for BZO:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>70.8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>148</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>224</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>390</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>452</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>504</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for MDMA:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>137</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>351</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>745</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>925</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for TCA:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>273</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>509</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>809</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1190</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1510</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1680</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for PPX:

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=2 colspan=1>Drug ConcentrationbyLC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>77.4</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>351</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>420</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>492</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Lay users also completed surveys on the ease of understanding the package insert instructions, and the results were found to be acceptable. A Flesch-Kincaid reading analysis was performed on the package insert and the scores revealed a reading grade level of 7.

3. Clinical Studies

Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Parts 801 and 809, as applicable.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.